The contribution of regulatory T-cells (Tregs) to systemic lupus erythematosus (SLE) pathogenesis remains a matter of debate. The objective of this study was to quantify the association between peripheral blood Tregs and disease status in SLE patients.
Method
EMBASE and PubMed databases were searched using ‘systemic lupus erythematosus’ and ‘regulatory T-cells’ as relevant key terms. A meta-analysis of studies that examined the proportion of Tregs among peripheral blood mononuclear cells (PBMCs) and CD4+T-cells was performed using Stata software. Subgroup analysis was performed based on ethnic groups and Treg definition markers.
Results
The Treg/PBMC and Treg/CD4+T-cell ratios were significantly lower in SLE patients than in healthy controls (HCs), whereas patients with active and inactive SLE showed no difference in these indicators. A subgroup analysis indicated that Asian SLE patients had a substantially lower proportion of Tregs/PBMCs than HCs, but this difference was not seen for white and Latin American SLE patients. Patients defined by CD4+CD25+Foxp3+, CD4+CD25+ and CD4+Foxp3+ had a much lower Treg/PBMC ratio compared with HCs. Ethnic groups and choice of Treg definition markers had no influence on the proportion of Tregs/CD4+T-cells.
Conclusion
The proportion of Tregs among both PBMCs and CD4+T-cells was significantly decreased in SLE patients. Ethnic group and Treg definition markers may influence the proportion of Tregs among PBMCs. Further study of the correlation between SLE disease activity and the proportion of Tregs in peripheral blood is needed to determine the physiological role of this association.
Momtazi-BorojeniAAHaftcheshmehSMEsmaeiliSAet al.Curcumin: a natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev2018; 17: 125–135.
3.
TsokosGC. Systemic lupus erythematosus. N Engl J Med2011; 365: 2110–2121.
4.
IwataSTanakaY. B-cell subsets, signaling and their roles in secretion of autoantibodies. Lupus2016; 25: 850–856.
5.
BettelliEDastrangeMOukkaM. Foxp3 interacts with nuclear factor of activated T-cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA2005; 102: 5138–5143.
6.
MurakamiNRiellaLV. Co-inhibitory pathways and their importance in immune regulation. Transplantation2014; 98: 3–14.
7.
WorkmanCJSzymczak-WorkmanALCollisonLWPillaiMRVignaliDA. The development and function of regulatory T-cells. Cell Mol Life Sci2009; 66: 2603–2622.
8.
HanYGuoQZhangMChenZCaoX. CD69 + CD4 + CD25-T-cells, a new subset of regulatory T-cells, suppress T-cell proliferation through membrane-bound TGF-beta 1. J Immunol2009; 182: 111–120.
9.
MiyaraMAmouraZParizotCet al.Global natural regulatory T-cell depletion in active systemic lupus erythematosus. J Immunol2005; 175: 8392–8400.
10.
BarathSAlekszaMTarrTet al.Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T-cells in patients with systemic lupus erythematosus. Lupus2007; 16: 489–496.
11.
Vitales-NoyolaMOceguera-MaldonadoBNino-MorenoPet al.Patients with systemic lupus erythematosus show increased levels and defective function of CD69(+) T regulatory cells. Mediators Inflamm2017; 2017: 2513829. .
12.
Gomez-MartinDDiaz-ZamudioMVanoyeGCrispinJCAlcocer-VarelaJ. Quantitative and functional profiles of CD4 + lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia. Clin Exp Immunol2011; 164: 17–25.
13.
PanXYuanXZhengYet al.Increased CD45RA + FoxP3(low) regulatory T-cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS One2012; 7: e34662.
14.
ZabinskaMKrajewskaMKoscielska-KasprzakKet al.CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) regulatory T-cell subsets in mediating autoimmune reactivity in systemic lupus erythematosus patients. Arch Immunol Ther Exp (Warsz)2016; 64: 399–407.
15.
MesquitaDde MeloCWAraujoJet al.Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T-cells. Scand J Rheumatol2011; 40: 41–50.
16.
VenigallaRKTretterTKrienkeSet al.Reduced CD4+, CD25-T-cell sensitivity to the suppressive function of CD4+, CD25 high, CD127-/low regulatory T-cells in patients with active systemic lupus erythematosus. Arthritis Rheum2008; 58: 2120–2130.
17.
Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol2010; 25: 603–605.
18.
TseliosKSarantopoulosAGkougkourelasIBouraP. CD4+CD25 high FOXP3 + T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study. Clin Exp Rheumatol2014; 32: 630–639.
19.
Dal BenERDoPCBaptistaTSBauerMEStaubHL. Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4(+)CD25(+)Foxp3(+) Treg and CD3(-)CD19(+) B cells. Rev Bras Reumatol2014; 54: 241–246.
20.
XingQSuHCuiJWangB. Role of Treg cells and TGF-beta1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Immunol Invest2012; 41: 15–27.
21.
CaiXYLuoMLinXJet al.[Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus]. Zhonghua Yi Xue Za Zhi2012; 92: 460–463.
22.
HabibagahiMHabibagahiZJaberipourMAghdashiA. Quantification of regulatory T-cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int2011; 31: 1219–1225.
23.
Vargas-RojasMICrispinJCRichaud-PatinYAlcocer-VarelaJ. Quantitative and qualitative normal regulatory T-cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus2008; 17: 289–294.
24.
Alvarado-SanchezBHernandez-CastroBPortales-PerezDet al.Regulatory T-cells in patients with systemic lupus erythematosus. J Autoimmun2006; 27: 110–118.
25.
LiuMFWangCRFungLLWuCR. Decreased CD4+CD25 + T-cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol2004; 59: 198–202.
26.
CrispinJCMartinezAAlcocer-VarelaJ. Quantification of regulatory T-cells in patients with systemic lupus erythematosus. J Autoimmun2003; 21: 273–276.
27.
MesquitaDJKirsztajnGMFrancoMFet al.CD4(+) T helper cells and regulatory T-cells in active lupus nephritis: an imbalance towards a predominant Th1 response?Clin Exp Immunol2018; 191: 50–59.
28.
El-MaraghyNGhalyMSDessoukiONasefSIMetwallyL. CD4+CD25-Foxp3 + T-cells as a marker of disease activity and organ damage in systemic lupus erythematosus patients. Arch Med Sci2018; 14: 1033–1040.
29.
WangXQiaoYYangLet al.Leptin levels in patients with systemic lupus erythematosus inversely correlate with regulatory T-cell frequency. Lupus2017; 26: 1401–1406.
30.
FerreiraRCSimonsHZThompsonWSet al.Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity. J Autoimmun2017; 84: 75–86.
31.
HandonoKFirdausiSNPratamaMZEndhartiATKalimH. Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus. Clin Rheumatol2016; 35: 631–638.
32.
Szmyrka-KaczmarekMKosmaczewskaACiszakLSzteblichAWilandP. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. Postepy Hig Med Dosw (Online)2014; 68: 893–898.
33.
SuenJLLiHTJongYJChiangBLYenJH. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology2009; 127: 196–205.
34.
YanBYeSChenGet al.Dysfunctional CD4+, CD25 + regulatory T-cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum2008; 58: 801–812.
35.
ZhaoSSLiXMLiXPet al.[Expression of CD4 + CD25 + CD127(low/-) T-cells in patients with systemic lupus erythematosus]. Zhonghua Yi Xue Za Zhi2008; 88: 453–456.
36.
LeeHYHongYKYunHJet al.Altered frequency and migration capacity of CD4+CD25 + regulatory T-cells in systemic lupus erythematosus. Rheumatology (Oxford)2008; 47: 789–794.
37.
BonelliMSavitskayaAvon DalwigkKet al.Quantitative and qualitative deficiencies of regulatory T-cells in patients with systemic lupus erythematosus (SLE). Int Immunol2008; 20: 861–868.
38.
AzabNABassyouniIHEmadYet al.CD4+CD25 + regulatory T-cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol2008; 127: 151–157. .
39.
LyssukEYTorgashinaAVSolovievSKNassonovELBykovskaiaSN. Reduced number and function of CD4+CD25highFoxP3 + regulatory T-cells in patients with systemic lupus erythematosus. Adv Exp Med Biol2007; 601: 113–119.
40.
LinSCChenKHLinCHet al.The quantitative analysis of peripheral blood FOXP3-expressing T-cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest2007; 37: 987–996.
41.
SuarezALopezPGomezJGutierrezC. Enrichment of CD4 + CD25high T-cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis2006; 65: 1512–1517.
42.
FathyAMohamedRWTawfikGAOmarAS. Diminished CD4+CD25 + T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol2005; 12: 25–31.
43.
Abstracts of the 10th International Congress on SLE. April 18–21, 2013. Buenos Aires, Argentina. Lupus 2013; 22(Suppl. 1): 1–196.
44.
ZhangSXMaXWLiYFet al.The proportion of regulatory T-cells in patients with systemic lupus erythematosus: a meta-analysis. J Immunol Res2018; 2018: 7103219.
45.
Yates J, Whittington A, Mitchell P, Lechler RI, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 2008; 153: 44–55.
46.
Nishimoto T, Hanaoka H, Okazaki Y, et al. Abstracts of the10th International Congress on SLE. April 18–21, 2013. Buenos Aires, Argentina. Lupus 2013; 22Suppl 1(1): 1–196.
47.
GovenderLPascualMGolshayanD. Potential and limitations of regulatory T-cell therapy in solid organ transplantation. Expert Rev Clin Immunol2014; 10: 1197–1212.
48.
KleinewietfeldMHaflerDA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol2013; 25: 305–312.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
